Targeting Epac2 and GluA3-
containing AMPARs: a novel
therapeutic strategy for Alzheimer’s
disease
Tong Zhang, Martina Schmidt*
Department of Molecular Pharmacology,
Groningen Research Institute of Pharmacy,
University of Groningen, Groningen, The
Netherlands (Zhang T, Schmidt M)
School of Pharmacy, Tianjin Medical University,
Tianjin, China (Zhang T)
Online:2025-11-15
Published:2025-02-23
Contact:
Martina Schmidt, PhD, m.schmidt@rug.nl.
Supported by:
We thank the Department of Molecular
Pharmacology and Molecular Neurobiology for the
support.
This work was supported by Alzheimer Nederland
grant [WE.03-2019-05] (to MS).